2024-04-25  9:47:51 PM Chg. -0.56 Volume Bid9:47:59 PM Ask- Market Capitalization Dividend Y. P/E Ratio
30.36USD -1.80% 38,391
Turnover: 1.16 mill.
30.36Bid Size: 200 -Ask Size: - 6.3 bill.USD 1.84% -

Business description

Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with a 130-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company(TM), Dentsply Sirona's products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. Dentsply Sirona's global headquarters is located in York, Pennsylvania, and the international headquarters is based in Salzburg, Austria. The company's shares are listed in the United States on NASDAQ under the symbol XRAY.
 

Management board & Supervisory board

CEO
Simon D. Campion
Management board
Glenn G. Coleman , Erania Brackett, Rich Rosenzweig, Andrew Robinson, Emily P. Miner, Tony Johnson , Andreas Frank, Andrea Frohning
Supervisory board
Eric K. Brandt, Betsy D. Holden, Clyde R. Hosein, Dr. Dorothea Wenzel, Gregory T. Lucier, Harry M. Jansen Kraemer, Jr., Janet S. Vergis, Leslie F. Varon, Simon D. Campion, Willie A. Deese, Jonathan J. Mazelsky
 

Company data

Name: DENTSPLY Sirona Inc.
Address: 13320 Ballantyne Corporate Place,,Charlotte, North Carolina 28277-3607, USA
Phone: +1-844-848-0137
Fax: -
E-mail: contact@dentsplysirona.com
Internet: www.dentsply.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 67.73%
IPO date: 1987-08-12

Investor relations

Name: Andrea Daley
IR phone: +1-717-849-8763
IR Fax: -
IR e-mail: InvestorRelations@de...ona.com InvestorRelations@dentsplysirona.com

Company calendar

CW 18 | 2024-05-02 Interim Report 1st Quarter/3 Months
CW 21 | 2024-05-24 General Shareholder Meeting